(Q37827197)

23 August 2017

1 reference

title

Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients (English)

1 reference

23 August 2017

S C Jordan

1

1 reference

23 August 2017

M Toyoda

series ordinal

2

1 reference

23 August 2017

J Kahwaji

series ordinal

3

1 reference

23 August 2017

A A Vo

series ordinal

4

1 reference

23 August 2017

language of work or name

English

0 references

publication date

10 January 2011

1 reference

American Journal of Transplantation

23 August 2017

published in

1 reference

23 August 2017

volume

11

1 reference

23 August 2017

issue

2

1 reference

23 August 2017

page(s)

196-202

1 reference

Anti-inflammatory actions of intravenous immunoglobulin

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2010.03400.X

Common variable immune deficiency and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2010.03400.X

Intravenous immunoglobulin a natural regulator of immunity and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2010.03400.X

Intravenous immunoglobulins--understanding properties and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2010.03400.X

Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2010.03400.X

A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2010.03400.X

Advances in diagnosing and managing antibody-mediated rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2010.03400.X

Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2010.03400.X

Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2010.03400.X

The use of immunoglobulin therapy for patients undergoing solid organ transplantation: an evidence-based practice guideline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2010.03400.X

Long-term benefit of intravenous immunoglobulins in cadaveric kidney retransplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2010.03400.X

Efficacy of induction therapy with ATG and intravenous immunoglobulins in patients with low-level donor-specific HLA-antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2010.03400.X

Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2010.03400.X

Renal transplantation in patients with positive lymphocytotoxicity crossmatches: one center's experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2010.03400.X

Rituximab and intravenous immune globulin for desensitization during renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2010.03400.X

Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2010.03400.X

Combined posttransplant prophylactic IVIg/anti-CD 20/plasmapheresis in kidney recipients with preformed donor-specific antibodies: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2010.03400.X

Intravenous immunoglobulin - indications and mechanisms in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2010.03400.X

Utility of peritransplant and rescue intravenous immunoglobulin and extracorporeal immunoadsorption in lung transplant recipients sensitized to HLA antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2010.03400.X

Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2010.03400.X

Comparison of combination Plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2010.03400.X

Impact of rituximab therapy for treatment of acute humoral rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2010.03400.X

Evidence for humoral rejection of a pancreatic islet graft and rescue with rituximab and IV immunoglobulin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2010.03400.X

Intravenous immunoglobulin as treatment for BK virus: nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2010.03400.X

Cellular immune responses to cytomegalovirus in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2010.03400.X

Long-term remission of recurrent severe anemia as a result of parvovirus B19 infection in a pediatric renal transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2010.03400.X

Treatment of parvovirus B-19 (PV B-19) infection allows for successful kidney transplantation without disease recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2010.03400.X

Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2010.03400.X

Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: a single-center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2010.03400.X

10.1111/J.1600-6143.2010.03400.X

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference